359 results on '"Cooper, Laurence J N"'
Search Results
2. Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
3. Author Correction: Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling
4. Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
5. An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models.
6. Chimeric Antigen Receptor on T Cells
7. Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.
8. Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
9. Engineering T Cells to Target Tumor Cells
10. Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies
11. Chimeric Antigen Receptor on T Cells
12. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
13. Visualizing Fewer than 10 Mouse T Cells with an Enhanced Firefly Luciferase in Immunocompetent Mouse Models of Cancer
14. Driving CAR-Based T-Cell Therapy to Success
15. Implications of Cooperativity and Dimensional Complexity for Immunological Recognition
16. CTIM-20. FINAL RESULTS OF CONTROLLED IL-12 MONOTHERAPY AND IN COMBINATION WITH PD-1 INHIBITOR IN ADULT SUBJECTS WITH RECURRENT GLIOBLASTOMA
17. CARs in Chronic Lymphocytic Leukemia – Ready to Drive
18. Chimeric Antigen Receptor on T Cells
19. Engineering T Cells to Target Tumor Cells
20. A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells
21. New approaches to allogeneic hematopoietic stem cell transplantation in pediatric cancers
22. A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19
23. Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
24. Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma
25. Very rapid cloning, expression and identifying specificity of T-cell receptors for T-cell engineering
26. Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction
27. Rapid Personalized Manufacture (RPM) of Sleeping Beauty System-Generated NY-ESO-1-Specific TCR-T Cells Co-Expressing Membrane-Bound IL-15 Yields Anti-Tumor Responses
28. Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
29. Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia
30. Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas
31. Steering CAR T cells to distinguish friend from foe
32. Abstract 2566: A TCL1-specific T-cell receptor redirects T cells against B-cell lymphomas and non-hematological tumors
33. Variable Region-Identical Monoclonal Antibodies of Different IgG Subclass Directed to Pseudomonas aeruginosa Lipopolysaccharide O-Specific Side Chain Function Differently
34. Steering CAR T cells to distinguish friend from foe.
35. Targeting B-cell malignancies through human B-cell receptor specific CD4+T cells
36. Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors
37. Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL
38. T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies
39. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer
40. Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application
41. Shortening the Time to Manufacture CAR+ T Cells with Sleeping Beauty System Supports T-Cell Engraftment and Anti-Tumor Effects in Patients with Refractory CD19+ Tumors
42. Long Term Follow up after Adoptive Transfer of CD19-Specific CAR+ T Cells Genetically Modified Via Non-Viral Sleeping Beauty S ystem Following Hematopoietic Stem Cell Transplantation (HSCT)
43. Autologous T Cells Modified to Co-Express CD33-Specific Chimeric Antigen Receptor and a Kill Switch for Treatment of CD33+ Acute Myeloid Leukemia
44. CD19-Specific Chimeric Antigen Receptor-Modified T Cells with Safety Switch Produced Under “Point-of-Care” Using the Sleeping Beauty System for the Very Rapid Manufacture and Treatment of B-Cell Malignancies
45. Don’t get lost in translation: How smart design and technology are enabling bench-to-bedside in translational research
46. The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity
47. Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations
48. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation
49. Clinical Applications of Gamma Delta T Cells with Multivalent Immunity
50. Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.